446 related articles for article (PubMed ID: 20363069)
1. Molecular mechanisms underlying tumor dormancy.
Almog N
Cancer Lett; 2010 Aug; 294(2):139-46. PubMed ID: 20363069
[TBL] [Abstract][Full Text] [Related]
2. Transcriptional switch of dormant tumors to fast-growing angiogenic phenotype.
Almog N; Ma L; Raychowdhury R; Schwager C; Erber R; Short S; Hlatky L; Vajkoczy P; Huber PE; Folkman J; Abdollahi A
Cancer Res; 2009 Feb; 69(3):836-44. PubMed ID: 19176381
[TBL] [Abstract][Full Text] [Related]
3. Prolonged dormancy of human liposarcoma is associated with impaired tumor angiogenesis.
Almog N; Henke V; Flores L; Hlatky L; Kung AL; Wright RD; Berger R; Hutchinson L; Naumov GN; Bender E; Akslen LA; Achilles EG; Folkman J
FASEB J; 2006 May; 20(7):947-9. PubMed ID: 16638967
[TBL] [Abstract][Full Text] [Related]
4. Genes and regulatory pathways involved in persistence of dormant micro-tumors.
Almog N
Adv Exp Med Biol; 2013; 734():3-17. PubMed ID: 23143972
[TBL] [Abstract][Full Text] [Related]
5. Tumor dormancy of primary and secondary cancers.
Udagawa T
APMIS; 2008; 116(7-8):615-28. PubMed ID: 18834406
[TBL] [Abstract][Full Text] [Related]
6. Tumor-vascular interactions and tumor dormancy.
Naumov GN; Folkman J; Straume O; Akslen LA
APMIS; 2008; 116(7-8):569-85. PubMed ID: 18834403
[TBL] [Abstract][Full Text] [Related]
7. Tumor-associated angiogenesis: mechanisms, clinical implications, and therapeutic strategies.
Pluda JM
Semin Oncol; 1997 Apr; 24(2):203-18. PubMed ID: 9129690
[TBL] [Abstract][Full Text] [Related]
8. Cancer dormancy: a model of early dissemination and late cancer recurrence.
Páez D; Labonte MJ; Bohanes P; Zhang W; Benhanim L; Ning Y; Wakatsuki T; Loupakis F; Lenz HJ
Clin Cancer Res; 2012 Feb; 18(3):645-53. PubMed ID: 22156560
[TBL] [Abstract][Full Text] [Related]
9. Tumor cell dormancy: implications for the biology and treatment of breast cancer.
Fehm T; Mueller V; Marches R; Klein G; Gueckel B; Neubauer H; Solomayer E; Becker S
APMIS; 2008; 116(7-8):742-53. PubMed ID: 18834416
[TBL] [Abstract][Full Text] [Related]
10. [Tumor dormancy and identification of therapeutic targets].
Li CF; Cao S; Meng SD
Ai Zheng; 2009 May; 28(5):555-8. PubMed ID: 19624889
[TBL] [Abstract][Full Text] [Related]
11. New clinical and experimental approaches for studying tumor dormancy: does tumor dormancy offer a therapeutic target?
Goss P; Allan AL; Rodenhiser DI; Foster PJ; Chambers AF
APMIS; 2008; 116(7-8):552-68. PubMed ID: 18834402
[TBL] [Abstract][Full Text] [Related]
12. Role of angiogenesis in human tumor dormancy: animal models of the angiogenic switch.
Naumov GN; Akslen LA; Folkman J
Cell Cycle; 2006 Aug; 5(16):1779-87. PubMed ID: 16931911
[TBL] [Abstract][Full Text] [Related]
13. Regulation of tumor dormancy as a function of tumor-mediated paracrine regulation of stromal Tsp-1 and VEGF expression.
Kang SY; Watnick RS
APMIS; 2008; 116(7-8):638-47. PubMed ID: 18834408
[TBL] [Abstract][Full Text] [Related]
14. The 'Sentinel Node' Concept: More Questions Raised than Answers Provided?
Schlag PM
Oncologist; 1998; 3(5):VI-VII. PubMed ID: 10388128
[TBL] [Abstract][Full Text] [Related]
15. Consensus micro RNAs governing the switch of dormant tumors to the fast-growing angiogenic phenotype.
Almog N; Ma L; Schwager C; Brinkmann BG; Beheshti A; Vajkoczy P; Folkman J; Hlatky L; Abdollahi A
PLoS One; 2012; 7(8):e44001. PubMed ID: 22952847
[TBL] [Abstract][Full Text] [Related]
16. Tumor dormancy and immunoescape.
Quesnel B
APMIS; 2008; 116(7-8):685-94. PubMed ID: 18834412
[TBL] [Abstract][Full Text] [Related]
17. Cellular interactions in the vascular niche: implications in the regulation of tumor dormancy.
Favaro E; Amadori A; Indraccolo S
APMIS; 2008; 116(7-8):648-59. PubMed ID: 18834409
[TBL] [Abstract][Full Text] [Related]
18. Vascular determinants of cancer stem cell dormancy--do age and coagulation system play a role?
Rak J; Milsom C; Yu J
APMIS; 2008; 116(7-8):660-76. PubMed ID: 18834410
[TBL] [Abstract][Full Text] [Related]
19. Framework models of tumor dormancy from patient-derived observations.
Klein CA
Curr Opin Genet Dev; 2011 Feb; 21(1):42-9. PubMed ID: 21145726
[TBL] [Abstract][Full Text] [Related]
20. Evading tumor evasion: current concepts and perspectives of anti-angiogenic cancer therapy.
Abdollahi A; Folkman J
Drug Resist Updat; 2010; 13(1-2):16-28. PubMed ID: 20061178
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
